All the news Showing 10 of 842 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Coronavirus COVID-19 slows viral hepatitis elimination, global survey finds Keith Alcorn / 22 February 2021 COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in laboratory capacity and telemedicine that will benefit future efforts to eliminate ... Coronavirus Hepatitis C does not raise the risk of death from COVID-19 Keith Alcorn / 19 February 2021 People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ... Diabetes & HCV Hepatitis C treatment reduces stroke and heart attack risk Keith Alcorn / 18 February 2021 Hepatitis C treatment reduces the risk of subsequent stroke or heart attack by between 25 and 35%, a meta-analysis of studies published in the Journal of Viral Hepatitis shows. People with hepatitis C ... Injecting drug use Hepatitis C declining among drug users in UK Keith Alcorn / 11 February 2021 The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since 2016, Public Health England reports. Around one in four ... Adherence to treatment High adherence and hepatitis C cure rates in active drug and alcohol users Keith Alcorn / 04 February 2021 People who use drugs achieved high rates of hepatitis C cure on direct-acting antiviral treatment despite ongoing drug and alcohol use, demonstrating that active drug use should not be a barrier to ... Hepatitis C elimination Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline Keith Alcorn / 27 January 2021 Hepatitis C is becoming more concentrated in gay and bisexual men with HIV in France as direct-acting antiviral treatment cures the infection in other people with HIV while hepatitis C transmission between ... Fibrosis HIV doubles the risk of liver fibrosis by middle-age, without viral hepatitis Michael Carter / 26 January 2021 Having HIV almost doubles the risk of liver fibrosis, according to European research published in the online edition of the Journal of Infectious Diseases. Investigators in Denmark and the Netherlands ... Coronavirus Will people with liver disease be prioritised for COVID-19 vaccination? Keith Alcorn / 19 January 2021 People with decompensated cirrhosis should be prioritised for COVID-19 vaccination and immunosuppressive treatment after a liver transplant should not be a barrier to vaccination, an international panel of liver experts has concluded. Their review ... Hepatitis C elimination What's needed to eliminate hepatitis C in people with HIV in Scotland? Keith Alcorn / 18 January 2021 To eliminate hepatitis C in people with HIV in Scotland, healthcare providers will need to reach people not on HIV treatment and step up testing for hepatitis C in people ... Access to medicines & diagnostics Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries Keith Alcorn / 08 January 2021 Public-sector hepatitis C treatment programmes have cured tens of thousands of people in lower- and lower-middle-income countries with the aid of low-cost direct-acting antivirals and diagnostics, a simplified approach to treatment and large-scale ... ← First12345...85Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds